Edith Borcoman

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Perioperative pembrolizumab in locally advanced head and neck cancer

Perioperative pembrolizumab in locally advanced head and neck cancer

Journal: Bulletin du cancer

Published: March 08, 2026

SCANDARE: an institutional dynamic prospective interventional biobanking study.

SCANDARE: an institutional dynamic prospective interventional biobanking study.

Journal: BMC cancer

Published: November 10, 2025

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

Journal: ESMO open

Published: June 06, 2025

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.

Journal: Oncoimmunology

Published: May 12, 2025

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.

Journal: Breast (Edinburgh, Scotland)

Published: April 29, 2025

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.

Journal: ESMO open

Published: January 21, 2025

The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.

The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.

Journal: ESMO real world data and digital oncology

Published: December 03, 2024

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.

Journal: Journal for immunotherapy of cancer

Published: November 25, 2024

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Journal: Nature cancer

Published: November 13, 2024

Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Journal: Nature communications

Published: October 31, 2024

Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study.

Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study.

Journal: Journal of intensive medicine

Published: April 09, 2024

Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal Carcinomatosis.

Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal Carcinomatosis.

Journal: The breast journal

Published: March 13, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026